Similar Papers

Paper Title
Journal
Date
Author
2002P - CXCR4, CCR2 and CCR5 expression in subsets of tumor cells with stem and/or EMT features
O.E Savelieva ... V.M Perelmuter
Annals of Oncology | VOL. 30
O.E Savelieva, et. al.O.E Savelieva ... V.M Perelmuter
01 Oct 2019
Оценка метастатических характеристик клеток с гибридным фенотипом при раке молочной железы
Rk Mukhamedzhanov ... Oe Savelieva
Bulletin of Russian State Medical University | VOL. -
Rk Mukhamedzhanov, et. al.Rk Mukhamedzhanov ... Oe Savelieva
01 Aug 2023
Juglone Inhibits Tumor Metastasis by Regulating Stemness Characteristics and the Epithelial-to-Mesenchymal Transition in Cancer Cells both in Vitro and in Vivo.
Xianwei Chen ... Shuang Ding
Frontiers in Bioscience-Landmark | VOL. 28
Xianwei Chen, et. al.Xianwei Chen ... Shuang Ding
08 Feb 2023
Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis.
Nattaporn Phanthaphol ... Watcharin Loilome
Oncology Letters | VOL. 14
Nattaporn Phanthaphol, et. al.Nattaporn Phanthaphol ... Watcharin Loilome
18 Sep 2017
View more papers

More From: Journal of Hepatology

Paper Title
Journal
Date
Author
Social Work in Emergency Management: Strengthening Prevention Networks and Support Systems for Global Liver Cancer Control.
Haoyu Liu
Journal of hepatology | VOL. -
Haoyu LiuHaoyu Liu
11 Jan 2025
Primary prophylaxis of acute variceal bleeding in patients with severe cirrhosis: Time for combination therapy?
Marika Rudler
Journal of hepatology | VOL. -
Marika RudlerMarika Rudler
11 Jan 2025
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial.
Jasmohan S Bajaj ... Alexander Khoruts
Journal of hepatology | VOL. -
Jasmohan S Bajaj, et. al.Jasmohan S Bajaj ... Alexander Khoruts
10 Jan 2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials.
Javier Armisen ... Rohit Loomba
Journal of hepatology | VOL. -
Javier Armisen, et. al.Javier Armisen ... Rohit Loomba
09 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.